Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons S.M. Hogeling

Publicaties

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia

Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia

Metformin induces ferroptosis associated with lipidomic remodeling in AML

Potent synergy of DHODH and SREBP inhibition in acute myeloid leukemia via disruption of cholesterol and lipid metabolism

The identification of novel therapeutic targets in acute myeloid leukemia

Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias

M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism

CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones

Dietary methionine starvation impairs acute myeloid leukemia progression

CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones